BLFS BioLife Solutions
- 19.540
- +1.530+8.50%
- 19.540
- 0.0000.00%
BioLife Solutions News
Several BioLife Solutions Insiders Sell Shares Sending Potential Negative Signal
BioLife Solutions, Inc. (NASDAQ:BLFS) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When evaluating insider transactions, knowing whether in
BioLife Solutions | 10-Q: Quarterly report
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2024 Earnings Call Transcript
Lake Street Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Xenon (XENE) and BioLife Solutions (BLFS)
BioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call Transcript
BioLife Solns (BLFS.US): The 2024 Q1 financial report achieved revenue of US$31.727 million, with a previous value of US$37.703 million, with an expected value of US$26.01 million; earnings per share of -0.20 USD, previous value of -0.27 USD, and expected
BioLife Solns (BLFS.US): The 2024 Q1 financial report achieved revenue of US$31.727 million, with a previous value of US$37.703 million, with an expected value of US$26.01 million; earnings per share of -0.20 USD, previous value of -0.27 USD, and expected value of -0.28 USD.
Earnings Flash (BLFS) BIOLIFE SOLUTIONS Posts Q1 Revenue $31.7M, Vs. Street Est of $24.9M
04:18 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (BLFS) BIOLIFE SOLUTIONS Posts Q1 Revenue $31.7M, vs. Street Est of $24.9M
BioLife Solutions Reiterates Guidance
2024 Revenue GuidanceBioLife Solutions is affirming its 2024 revenue guidance of $95.5 million to $100.0 million. This is based on expectations for BioLife's Cell Processing and Biostorage Services pl
BioLife Solns Q1 2024 GAAP EPS $(0.22) Beats $(0.28) Estimate, Sales $16.20M Miss $26.01M Estimate
BioLife Solns (NASDAQ:BLFS) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.28) by 21.43 percent. The company reported quarterly sales of $16.20 millio
BioLife Solutions 1Q Loss $10.2M >BLFS
BioLife Solutions 1Q Loss $10.2M >BLFS
Press Release: BioLife Solutions Reports First Quarter 2024 Financial Results
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire BOTHELL, Wash., May 9, 2024 Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38%
BioLife Solutions (BLFS) Receives a Buy From Craig-Hallum
BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
BOTHELL, Wash., April 30, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") an
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Intra-Cellular Therapies (ITCI)
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Alimera (ALIM)
Meta Platforms, Pure Storage And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by around 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades.When insiders sell shares, it could be a preplanned sale, or could indicate t
BioLife Solutions, Inc. (NASDAQ:BLFS) Investors Are Less Pessimistic Than Expected
When you see that almost half of the companies in the Life Sciences industry in the United States have price-to-sales ratios (or "P/S") below 3.5x, BioLife Solutions, Inc. (NASDAQ:BLFS) looks to be gi
Insider Sell: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ...
BioLife Solutions(BLFS.US) Officer Sells US$156.7K in Common Stock
$BioLife Solutions(BLFS.US)$ Officer Berard Todd sold 10,000 shares of common stock on Apr 15, 2024 at an average price of $15.67 for a total value of $156.7K.Source: Announcement What is statement of
Analysis
Price Target
No Data
